ilex paraguariensis extracts inhibit age formation more efficiently than green tea
TRANSCRIPT
Fitoterapia 76 (2005) 419–427
www.elsevier.com/locate/fitote
Ilex paraguariensis extracts inhibit AGE formation
more efficiently than green tea
Nicole Lunceford, Alejandro Gugliucci*
Glycation, Oxidation and Disease Laboratory, Division of Basic Medical Sciences, Touro University-California,
Mare Island, Vallejo, CA, USA
Received 24 November 2004; accepted 16 March 2005
Available online 13 May 2005
Abstract
Glycation, the nonenzymatic adduct formation between sugar dicarbonyls and proteins, is one
key molecular basis of diabetic complications due to hyperglycemia. Given the link between
glycation and oxidation, we hypothesized that herbal extracts with a high concentration of
antioxidant phenolics might possess significant in vitro antiglycation activities as well. The aim of
the present study was to address the hypothesis that polyphenol-rich Ilex paraguariensis (IP)
extracts are capable of inhibiting advanced glycation end-products (AGEs) formation and to
compare the potency of these extracts with green tea and with the standard antiglycation agent
aminoguanidine. When we studied the effects of IP extract on AGE fluorescence generated on
bovine serum albumin ( BSA) by glycation with methylglyoxal, a dose-dependent effect that
reaches 40% at 20 Al/ml of extract was demonstrated. Green tea did not display any significant
effect. IP polyphenols are about 2- to 2.5-fold higher in our preparations compared with green tea.
The effect of IP, therefore, may be due not only to the higher concentrations but to the different
composition in phenolics of the two botanical preparations as well. To better discriminate between
an antioxidant or a carbonyl quenching mechanism of action, we explored tryptophan fluorescence
and cross-linking by sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) electrophoresis.
The conformational changes induced by glycation and substitution of positive charges in arginine
and/or lysine produce a decrease in tryptophan fluorescence. We show that incubation of BSA with
methylglyoxal produces dramatic changes in tryptophan fluorescence that are prevented by
aminoguanidine. This also prevents the downstream effect of AGE formation. Neither green tea
nor IP extracts displayed any significant effect which rules out any significant participation as
0367-326X/$
doi:10.1016/j.
* Correspon
E-mail add
- see front matter D 2005 Elsevier B.V. All rights reserved.
fitote.2005.03.021
ding author. Tel.: +1 707 638 5237; fax: +1 707 638 5255.
ress: [email protected] (A. Gugliucci).
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427420
inhibitors in the first phase of the glycation cascade. The results from the SDS-PAGE serve to
confirm the above-mentioned data. The effect is therefore due mainly to an inhibition of the second
phase of the glycation reactions, namely the free-radical mediated conversion of the Amadori
products to AGE.
Taken together our results demonstrate a significant, dose-dependent effect of water extracts of I.
paraguensis on AGE adducts formation on a protein model in vitro, whereas green tea displays no
significant effect. The inhibition of AGE formation was comparable to that obtained by using
millimolar concentrations of the standard antiglycation agent aminoguanidine.
D 2005 Elsevier B.V. All rights reserved.
Keywords: Ilex paraguariensis; Green tea; Antioxidant; Polyphenols; Methylglyoxal; Glycation; Diabetes
1. Introduction
Glycation, the nonenzymatic adduct formation between sugar aldehydes and
proteins, is one key molecular basis of diabetic complications due to hyperglycemia
[1]. In the glycation reaction, sugars react non-enzymatically with proteins and lipids to
form early glycation (Amadori or fructosamine) products. Alpha-dicarbonyl compounds
such as deoxyglucosone, methylglyoxal, and glyoxal (AGE precursors) form afterwards
by oxidation and are more reactive than the parent sugars vis-a-vis amino groups of
proteins. They form stable end-products called advanced Maillard products or advanced
glycation end-products (AGEs). The AGEs, which are irreversibly formed, accumulate
with aging, atherosclerosis, and diabetes mellitus, and are especially associated with
long-lived proteins such as collagens, lens crystallins, and nerve proteins [2–4].
Glycated proteins accumulated in vivo may provide stable active sites for catalyzing
the formation of free radicals, hence glycation and glycoxidation are intimately
interrelated [3,4].
The glycation inhibitor aminoguanidine attenuates the development of a range of
diabetic vascular complications [5]. However, some problems of toxicity have been
encountered in clinical trials with aminoguanidine, so this drug should be considered a
prototype for many new molecules which are being synthesized and tried in vitro at
present [6,7]. Another mostly unexplored avenue is the search for botanical compounds
that may inhibit the process and be a source of proto-drugs. Particularly interesting in this
regard are some herbal preparations, which have actually passed the test of time in terms of
toxicity or adverse effects. Given the link mentioned above between glycation and
oxidation, we hypothesized that herbal extracts with a high concentration of antioxidant
phenolics might possess significant in vitro anti-glycation activities as well.
In particular, our laboratory has been the first to report strong antioxidant properties in
vitro, cell culture and in vivo of Ilex paraguariensis, known as bmateQ for the Spanish-
speaking or bchimarraoQ for the Portuguese-speaking populations of South America [8–
11]. I. paraguariensis extracts are used in complementary and alternative medicine and as
a very popular folk beverage dating from pre-Colombian times in large regions of South
America. This beverage has gained popularity in the United States in the last few years. I.
paraguariensis St. Hill. (Aquifoliaceae) is a widely distributed tree or shrub in Southern
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427 421
Brazil, North-eastern Argentina, Paraguay, and Uruguay. Its dried and ground leaves
(yerba mate) are used to prepare this traditional beverage and are included in medicinal
preparations as a mild CNS stimulant, diuretic, and in weight reducing preparations [12–
17]. The mate-drinking habit has been popular for centuries, and was adopted from the
native inhabitants of the region (Guaranıes). The Jesuits managed to develop plantations
from the wild species which were used as the economic basis for their system of missions
in Paraguay, North-eastern Argentina, and Rio Grande do Sul (Brazil). The product, which
was even shipped to Europe, was known as bJesuit’s teaQ, bParaguayan teaQ, or bmate teaQ.Nowadays, it is grown in Argentina and is exported to the United States, Europe, and Asia
where it is sold as dried drug material or as extracts in different medicinal, cosmetic
preparations, or as an ingredient in foods. Mate contains purine alkaloids (methyl
xanthines), flavonoids, vitamins such as vitamin A, the B complex, C and E, tannins,
chlorogenic acid and its derivatives, and numerous triterpenic saponins derived from
ursolic acid, known as matesaponins [12–17]. Though the presence of methyl xanthines
account for many of the pharmacological activities of yerba mate, many other very
interesting and important properties have been found to be independent of the presence of
these compounds. Mate extracts polyphenol levels are higher than those of green tea and
parallel those of red wines [18]. Mate also contains saponins that are known to bind bile
salts. There are, to our knowledge, only three reports in the literature showing
antiglycation effects of herbal compounds, one focused on thyme [19], the other on
green tea [20], and the third is a previous study showing that IP extracts protect proteins
from functional loss after early glycation [21]. The aim of the present study was to address
the hypothesis that polyphenol-rich IP extracts are capable of inhibiting AGE formation
and to compare the potency of these extracts with green tea and the standard antiglycation
agent aminoguanidine.
2. Materials and methods
2.1. General
Spectrophotometric measurements were made with a Beckman DU 640 Spectropho-
tometer (Beckman Coulter Inc., Fullerton, CA). Protein concentrations were measured by
the Bradford method [22] (BioRad, Hercules, CA).
2.2. Glycation protocol
BSA (Sigma A-7030, St Louis, MO) in 10 mmol/l sodium phosphate buffer, pH 7.4
containing 150 mmol/l NaCl and 3.7 mmol/l EDTA, to a final protein concentration of 1
mg/ml. After filtering through a 0.45 Am Millipore filter, BSA was incubated in sterile
conditions in the absence or presence of methylglyoxal (5 mmol/l final concentration) at
37 8C for a period of 0–6 days [23]. Samples were incubated in the presence or absence of
extracts of green tea, IP (2–20 Al/ml), or aminoguanidine (1–10 mmol/l). After incubation,
samples were extensively dialyzed against 10 mmol/l sodium phosphate buffer, pH 7.4
containing 150 mmol/l NaCl and kept frozen at �80 8C until analysis [23].
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427422
2.3. Preparation of I. paraguariensis extract
I. paraguariensis powdered dry leaves (dyerba mateT) from commercial sources
(Canarias, Pando Uruguay) was freshly prepared into a mate infusion (50 g/l of herb in
water at 90 8C) in a gourd. The extracts were filtered through a 0.45 mm Millipore filter
and used the same day. The inter-assay coefficient of variation (CV) of the total
polyphenol content of the different preparations was less than 10%. Green tea (in tea bags)
were obtained from commercial sources and infusions were prepared (5 g/200 ml water).
All comparative studies between the herbal preparations were done extemporaneously.
2.4. Determination of polyphenol concentration
Total polyphenol concentrations in IP samples were determined spectrophotometrically
with the Folin–Ciocalteau phosphomolybdic–phosphotungstic acid reagents as modified
by Vinson [24].
2.5. Analysis of protein conformation changes
Tryptophan fluorescence quenching by glycation was determined as fluorescence
spectra at Ex 280 nm using a Shimadzu RS-5301 PC Spectrofluorometer with HyperRS
1.57 software for data analysis. Samples were diluted to 50 Ag/ml protein concentration
[23].
2.6. Analysis of AGE formation
AGE fluorescence spectra were determined at Ex 340 nm using the same equipment
and dilutions as above [23].
2.7. SDS-PAGE
Electrophoresis was run on 10% gels (reducing conditions). Each lane was loaded with
10 Ag protein. Equipment employed was Mini Gel III from BioRad (BioRad, Hercules,
CA). Gels were stained with Coomassie brilliant blue.
2.8. Statistical analysis
Unless otherwise stated, data are expressed as meanFS.D. Comparisons between data
were performed by the Student’s t-test (two-tailed) for unpaired samples. Data was
processed on SPSS 12.0.
3. Results
The polyphenol content in the preparations was 2.6F0.2% for I. paraguariensis and
1.1F0.2% for green tea extracts.
0
50
100
150
200
250
300
350
400
450
500
300 350 400
wavelength, nm
Try
pto
ph
an f
luo
resc
ence
, AU
MG
MG + IP 10µl/ml
MG + IP 20µl/ml
Control
0
50
100
150
200
250
300
350
400
450
500
300 350 400
Control
MG + GT10 µl/ml
MG + GT20 µl/ml
MG
A B C
0
50
100
150
200
250
300
350
400
450
500
300 350 400
wavelength, nm
Try
pt.
Flu
ore
scen
ce, A
U
Control
MG
MG + 10
mmol/l
AG
Fig. 1. Tryptophan fluorescence spectra from control (BSA) incubated in vitro for 6 days at 37 8C in the absence
or presence of 5 mmol/l methyglyoxal (MG) or 5 mmol/l methyglyoxal and two concentrations of IP or two
concentrations of GT or 10 mmol of aminoguanidine as positive control. Spectra were measured after excitation at
280 nm.
0
10
20
30
40
50
60
70
340 360 380 400 420 440 460 480 500
wavelength, nm
AG
E f
luo
resc
ence
, AU
MG
MG + IP 10 µl/ml
MG + IP 20 µl/ml
MG + IP 4 µl/ml
Control
0
10
20
30
40
50
60
70
350 400 450 500
wavelength, nm
AG
E f
luo
resc
ence
, AU
MG
MG + 10mmol/l AG
Control
Fig. 2. AGE fluorescence spectra from control (BSA) incubated in vitro for 6 days at 37 8C in the absence or
presence of 5 mmol/l methyglyoxal or 5 mmol/l methyglyoxal and three concentrations of IP extract. Spectra
were measured after excitation at 340 nm. The inset depicts the AGE fluorescence spectra of BSA incubated
presence of 5 mmol/l methyglyoxal with or without 10 mmol/l aminoguanidine.
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427 423
30
35
40
45
50
55
60
65
70
0 5 10 15 20 25
extract concentration, µl/ml
AG
E fl
uo
resc
ence
(Ex:
340
/ Em
: 420
nm
; AU
)
Ilex paraguariensis
green tea
Fig. 3. Dose dependency of the effect of IP and GT extracts on AGE fluorescence spectra. BSAwas incubated in
vitro for 6 days at 37 8C in the absence or presence of 5 mmol/l methyglyoxal or 5 mmol/l methyglyoxal and five
concentrations of IP or GT extracts. AGE fluorescence at Ex 340/Em 420 (the main peak in Fig. 1) was measured.
Data represent meanFS.D. of two independent experiments in which each condition was analyzed in duplicates.
Differences between activities at 2, 4 and 10 and 20 Al/ml IP versus MG are significant ( P b0.005). Differences
between MG and any of the concentrations of GT are not significant.
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427424
Fig. 1 depicts the changes in tryptophan fluorescence spectra produced in BSA after
incubation with methylglyoxal with or without co-incubation with IP (A), green tea (B), or
aminoguanidine (C) as a standard antiglycation agent. Tryptophan fluorescence is
quenched by more than 90% after glycation with methylglyoxal. No significant effect is
shown for IP (A) or green tea (B) at all the concentrations employed. As expected,
aminoguanidine (C) restored the fluorescence to ca. control values.
Fig. 2 depicts the AGE fluorescence spectra when incubated BSA samples were excited
at 340 nm. Control BSA shows no significant signal. When BSA is incubated with
methylglyoxal, fluorescent products are formed, with a major peak at 420 nm. When BSA
is co-incubated with methylglyoxal, and increasing concentrations of IP extracts inhibition
of the AGE fluorescence are shown. For comparison, as positive control we show, in the
inset, the effect of 10 mmol/l aminoguanidine (supra-pharmacological concentrations),
which reduces fluorescence more than 90%.
Fig. 3 reports the comparative effects of IP and green tea on AGE fluorescence
emission at the main peak of 420 nm shown in Fig. 2. IP produces a dose-dependent
Control MG MG + GT MG + IP
70 kDa
Fig. 4. SDS-PAGE of BSA incubated in vitro for 6 days at 37 8C in the absence or presence of 5 mmol/l
methyglyoxal (MG) or 5 mmol/l MG and IP or GT at 20 Al/ml. Gels (10%) were loaded with 10 Ag protein/lane
and stained with Coommassie.
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427 425
inhibition in AGE accumulation, reaching 40% at 20 Al/ml. By comparison, no significant
effects were found for green tea at all the concentrations explored.
Fig. 4 shows SDS-PAGE profiles for BSA incubated in the absence (control) or
presence of methylglyoxal (MG), and co-incubated with MG and green tea at 20 Al/l(MG+GT) or MG and IP at 20 Al/l (MG+IP). Incubation with MG leads to the appearance
of a second band at 90 kDa that most likely represents cross-linked BSA with minor low
molecular weight protein contaminants that disappear from the gel. No significant effects
were found for green tea or IP at all the concentrations explored.
4. Discussion
Advanced glycation end-products are well-known contributors to the pathophysiology
of aging and diabetic chronic complications [1,2]. We decided to employ methylglyoxal
(MG) as a fast, reproducible way of generating AGEs on proteins. This model produces
very stringent glycation conditions, facilitating its detection [9,23,25]. On the other hand,
if inhibitory effects are detected in preparations under analysis, these effects need to be
strong [23,25]. Endogenously produced dicarbonyls, such as methylglyoxal, are involved
in numerous pathogenic processes in vivo, including advanced glycation end-product
formation. MG is produced in vivo as a by-product of glycolysis, from glycation of
proteins by glucose, as a product of lipid peroxidation, and from the metabolism of
acetone and threonine [9,23,25].
The effect of IP extract on AGE fluorescence in the presence of methylglyoxal was
tested and a dose-dependent effect was observed that reaches 40% with 20 Al/ml. Green
tea, in analogous conditions, did not show a really significant effect. However, a positive
trend suggests a possible mild effect of GT. As previously reported, a mild activity of
green tea vis-a-vis fluorescent AGE adducts formation was shown [20]. IP polyphenols are
about 2- to 2.5-fold higher in our preparations as compared to green tea. Nevertheless, the
effect of IP could be due to the different composition in phenolics of the two botanical
preparations and not only to the different concentrations [8–18,21,26–30]. Glycated
proteins have been shown to provide stable active sites for catalyzing the formation of free
radicals through an enzyme-like mechanism that mimics the characteristics of metal-
catalyzed oxidation systems [3,7]. These free radical reactions lead to the formation of
fluorescent and non-fluorescent AGE adducts. The action of IP could be mediated by an
effect on these latter reactions and/or by a direct nucleophilic scavenger action in the first
phase of glycation. As ethylendiamine tetraacetic acid (EDTA) was present at 3.7 mmol/l
in the incubation buffer, a chelating effect of the polyphenol-rich extracts can be ruled out.
To better discriminate between these two putative mechanisms of action we explored
tryptophan fluorescence and cross-linking by SDS-PAGE.
Tryptophan fluorescence can be quenched by changes in the protein structure induced
by chemicals. The slight conformational changes induced by glycation and substitution of
positive charges in arginine and/or lysine produce a decrease in tryptophan fluorescence
[23]. This approach is extensively used in glycation research [23]. We show here that
incubation of BSA with methylglyoxal produces dramatic changes in tryptophan
fluorescence that are prevented by aminoguanidine. Aminoguanidine acts as a nucleophilic
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427426
scavenger, preventing the first reaction in glycation from occurring. This, of course, also
prevents the downstream effect of AGE formation. Neither green tea nor IP extracts
displayed any significant effect on these changes which rules out any significant
participation as inhibitors in the first phase of the glycation cascade. The results from the
SDS-PAGE serve to confirm the above-mentioned data, IP or green tea do not significantly
affect the cross-linking induced by the dicarbonyl, since they do not alter this first reaction.
The effect is therefore due mainly to an inhibition of the second phase of the glycation
reactions, namely the free-radical mediated conversion of the Amadori products to AGE.
These data suggest that I. paraguariensis extracts exert these effects mainly through their
antioxidant and free radical quenching capacity, which is greater than those of green tea
and red wines as we have previously reported [18]. These data are also in agreement with
those from Baynes [3] who has shown that at the millimolar concentrations of AGE
inhibitors used in many in vitro studies, inhibition of AGE formation results primarily
from antioxidant activity of the AGE inhibitors, rather than their carbonyl trapping activity
[7]. This is also supportive of the hypothesis that fostered our study.
Taken together, our results suggest a significant, dose-dependent effect of water extracts
of I. paraguariensis on AGE adducts formation on a protein model in vitro, whereas green
tea displays no significant effect. In the systems employed, an effect is already significant
at concentrations of the extracts which correspond to a 1:100 dilution of the preparations
usually drunk. The inhibition of AGE formation was comparable to that obtained by using
millimolar concentrations of the standard antiglycation agent aminoguanidine. I.
paraguariensis could be a natural candidate for studies of herbal complement to diabetes
treatment since it combines antioxidant and anti-AGE formation activities.
Acknowledgements
The authors are grateful to Mr. John Schulze for his excellent technical assistance. This
work was funded by an intramural grant from Touro University to AG.
References
[1] Gugliucci A. J Am Osteopath Assoc 2000;100:621.
[2] Bonnefont-Rousselot D. Curr Opin Clin Nutr Metab Care 2002;5:561.
[3] Baynes JW, Thorpe SR. Free Radic Biol Med 2000;28:1708.
[4] Wiernsperger N. Biofactors 2004;19:11.
[5] Sell DR, Nelson JF, Monnier VM. J Gerontol A Biol Sci Med Sci 2001;56:B405.
[6] Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, et al. Diabetologia 2001;44:108.
[7] Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, et al. Kidney Int
2002;61:939.
[8] Gugliucci A. Biochem Biophys Res Commun 1996;224:338.
[9] Gugliucci A, Menini T. Life Sci 2002;72:279.
[10] Bracesco N, Dell M, Rocha A, Menini T, Gugliucci A, Nunes E. J Altern Complement Med 2003;9:379.
[11] Gugliucci A, Stahl AJ. Biochem Mol Biol Int 1995;35:47.
[12] Filip R, Ferraro G. Eur J Nutr 2003;42:50.
[13] Chandra S, De Mejia Gonzalez E. J Agric Food Chem 2004;252:3583.
N. Lunceford, A. Gugliucci / Fitoterapia 76 (2005) 419–427 427
[14] Filip R, Lopez P, Giberti G, Coussio J, Ferraro G. Fitoterapia 2001;72:774.
[15] Kraemer KH, Taketa AT, Schenkel EP, Gosmann G, Guillaume D. Phytochemistry 1006; 42:1119.
[16] Muccillo Baisch A, Johnston K, Paganini Stein F. J Ethnopharmacol 1998;60:133.
[17] Pomilio A, Trajtemberg S, Vitale A. Phytochem Anal 2002;13:235.
[18] Bixby M, Spieler L, Menini T, Gugliucci A. Life Sci in press [Available online 9 February 2005].
[19] Morimitsu Y, Yoshida K, Esaki S, Hirota A. Biosci Biotechnol Biochem 1995;59:2018.
[20] Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. J Agric Food Chem 2002;50:2418.
[21] Gugliucci A, Menini T. Life Sci 2002;72:279.
[22] Bradford MM. Anal Biochem 1976;72:248.
[23] Nagaraj RH, Oya-Ito T, Padayatti PS, Kumar R, Mehta S, West K, et al. Biochemistry 2003;42:10746.
[24] Vinson JJ, Proch J, Bose P. Methods Enzymol 2001;335:103.
[25] Chaplen FW, Fahl WE, Cameron DC. Proc Natl Acad Sci U S A 1998;95:5533.
[26] Tachibana H, Koga K, Fujimura Y, Yamada K. Nat Struct Mol Biol 2004;11:380.
[27] Young JF, Dragstedt LO, Haraldsdottir J, Daneshvar B, Kal MA, Loft S, et al. Br J Nutr 2002;87:343.
[28] Rababah T, Hettiarachchy N, Horax R. J Agric Food Chem 2004;52:5183.
[29] Schenkel E, Montanha J, Gosmann G. Adv Exp Med Biol 1996;405:47.
[30] Schinella GR, Troiani G, Davila V, de Buschiazzo PM, Tournier HA. Biochem Biophys Res Commun
2000;269:357.